Advertisement
Canada markets close in 4 hours 20 minutes

  • S&P/TSX

    21,803.54
    -70.18 (-0.32%)
     

  • S&P 500

    5,011.18
    -60.45 (-1.19%)
     

  • DOW

    37,869.25
    -591.67 (-1.54%)
     

  • CAD/USD

    0.7302
    +0.0005 (+0.06%)
     

  • CRUDE OIL

    82.22
    -0.59 (-0.71%)
     

  • Bitcoin CAD

    87,461.10
    -1,352.78 (-1.52%)
     

  • CMC Crypto 200

    1,374.81
    -7.76 (-0.56%)
     

  • GOLD FUTURES

    2,344.80
    +6.40 (+0.27%)
     

  • RUSSELL 2000

    1,967.38
    -28.05 (-1.41%)
     

  • 10-Yr Bond

    4.7040
    +0.0520 (+1.12%)
     

  • NASDAQ

    15,455.08
    -257.67 (-1.64%)
     

  • VOLATILITY

    16.88
    +0.91 (+5.69%)
     

  • FTSE

    8,077.42
    +37.04 (+0.46%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6810
    -0.0009 (-0.13%)
     
BREAKING:

HONDA TO SET UP $15B EV PRODUCTION BASE IN CANADA

Automaker to get up to $5B in government assistance for EV battery, assembly plants

Emerald Health Therapeutics Retains Listing Agent to Sell Previously-Closed Greater Vancouver Cannabis Cultivation Facility

Newsfile Corp.
·1 min read

Vancouver, British Columbia--(Newsfile Corp. - July 23, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has retained BC Farm & Ranch Realty Corp., a real estate agent dedicated 100% to agricultural properties, to assist in the sale of its licensed greenhouse cannabis production facility in Greater Vancouver, British Columbia.

As previously announced, Emerald ceased operations at this facility on March 31, 2021, and continues to operate its defined-scale production facility for premium cannabis in St. Eustache, Quebec, and its two separate new product development and processing facilities in British Columbia.

About Emerald Health Therapeutics, Inc.

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products, with an emphasis on science-based innovation and product excellence.

ADVERTISEMENT

Please visit www.emeraldhealth.ca for more information or contact:

Jenn Hepburn, Chief Financial Officer
1(800) 757 3536 Ext. #5
Emerald Investor Relations
(800) 757 3536 Ext. #5
invest@emeraldhealth.ca

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/91111